Alzamend Neuro, Inc.
ALZN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001677077
In the last 90 days, Alzamend Neuro, Inc. insiders filed 1 open-market purchase and 1 sale; 12 institutions reported holding it in 13F filings for Q2 2026, worth $3.26M in total; no superinvestor holds it.
Holders of 5% or more of ALZN
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Alzamend Neuro, Inc., largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of Alzamend Neuro, Inc. on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
6 Schedule 13D and 13G filings on Alzamend Neuro, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Oct 7, 20259:53 PM ET | Ault Milton C IIIand 8 others | 13D/A | 4.40%166.9K shares | −3.60 ppfrom 8.00%Below 5% | Oct 3, 2025 | SEC |
| Oct 3, 20259:37 PM ET | Ault Milton C IIIand 8 others | 13D/A | 8.00%306.3K shares | −3.20 ppfrom 11.20% | Oct 1, 2025 | SEC |
| Sep 30, 20258:51 PM ET | Ault Milton C IIIand 8 others | 13D/A | 11.20%429.7K shares | −2.10 ppfrom 13.30% | Sep 26, 2025 | SEC |
| Sep 25, 20259:37 PM ET | Ault Milton C IIIand 8 others | 13D/A | 13.30%509.3K shares | −2.60 ppfrom 15.90% | Sep 23, 2025 | SEC |
| Sep 23, 20254:30 PM ET | Ault Milton C IIIand 8 others | 13D/A | 15.90%606.3K shares | −2.60 ppfrom 18.50% | Sep 19, 2025 | SEC |
| Aug 1, 20258:52 PM ET | Ault Milton C IIIand 8 others | 13D/A | 18.50%706.3K shares | – | Jul 23, 2025 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Alzamend Neuro, Inc. shares.
No Form 144 notices for Alzamend Neuro, Inc. are on file.